Christian Ehmann
Stock Analyst at Berenberg Bank
(0.51)
# 4,369
Out of 5,126 analysts
197
Total ratings
42.4%
Success rate
-3.9%
Average return
Main Sectors:
Stocks Rated by Christian Ehmann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: DRW3 Drägerwerk AG & Co. KGaA | Upgraded: Buy | €85.00 → €156.00 | €109.60 | +42.34% | 22 | Nov 11, 2026 | |
| ETR: EVT Evotec SE | Reiterated: Hold | €3.60 → €3.75 | €3.16 | +18.67% | 42 | Nov 6, 2026 | |
| ETR: FYB Formycon AG | Reiterated: Buy | €30.00 | €14.96 | +100.53% | 16 | Oct 26, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Hold | €24.00 | €31.92 | -24.81% | 15 | Sep 3, 2026 | |
| ETR: EUZ Eckert & Ziegler SE | Reiterated: Buy | €23.00 | €13.93 | +65.11% | 1 | Aug 26, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Reiterated: Buy | €24.00 → €27.00 | €24.50 | +10.20% | 8 | Aug 14, 2026 | |
| SWX: KURN Kuros Biosciences AG | Initiated Coverage: Buy | CHF 32.00 | CHF 20.10 | +59.20% | 1 | Jul 7, 2026 | |
| ETR: DMP Dermapharm Holding SE | Reiterated: Hold | €41.00 | €38.60 | n/a | 4 | Aug 26, 2025 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €47.00 | €52.82 | n/a | 23 | May 7, 2025 | |
| ETR: M12 M1 Kliniken AG | Reiterated: Buy | €26.00 → €28.00 | €19.48 | n/a | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €43.00 | €40.81 | n/a | 20 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.80 → €5.90 | €2.67 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €5.60 | €2.40 | n/a | 1 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.50 → €17.90 | €0.88 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €30.00 → €33.00 | €13.10 | n/a | 10 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €41.00 → €56.00 | €0.77 | n/a | 2 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €4.20 → €3.50 | €0.01 | n/a | 3 | May 5, 2022 |
Drägerwerk AG & Co. KGaA
Nov 11, 2026
Upgraded: Buy
Price Target: €85.00 → €156.00
Current: €109.60
Upside: +42.34%
Evotec SE
Nov 6, 2026
Reiterated: Hold
Price Target: €3.60 → €3.75
Current: €3.16
Upside: +18.67%
Formycon AG
Oct 26, 2026
Reiterated: Buy
Price Target: €30.00
Current: €14.96
Upside: +100.53%
Gerresheimer AG
Sep 3, 2026
Reiterated: Hold
Price Target: €24.00
Current: €31.92
Upside: -24.81%
Eckert & Ziegler SE
Aug 26, 2026
Reiterated: Buy
Price Target: €23.00
Current: €13.93
Upside: +65.11%
SCHOTT Pharma AG & Co. KGaA
Aug 14, 2026
Reiterated: Buy
Price Target: €24.00 → €27.00
Current: €24.50
Upside: +10.20%
Kuros Biosciences AG
Jul 7, 2026
Initiated Coverage: Buy
Price Target: CHF 32.00
Current: CHF 20.10
Upside: +59.20%
Dermapharm Holding SE
Aug 26, 2025
Reiterated: Hold
Price Target: €41.00
Current: €38.60
Upside: n/a
Fresenius SE & Co. KGaA
May 7, 2025
Reiterated: Buy
Price Target: €47.00
Current: €52.82
Upside: n/a
M1 Kliniken AG
May 6, 2025
Reiterated: Buy
Price Target: €26.00 → €28.00
Current: €19.48
Upside: n/a
Feb 25, 2025
Reiterated: Hold
Price Target: €43.00
Current: €40.81
Upside: n/a
Nov 11, 2024
Reiterated: Buy
Price Target: €12.80 → €5.90
Current: €2.67
Upside: n/a
Feb 7, 2024
Reiterated: Hold
Price Target: €5.60
Current: €2.40
Upside: n/a
Dec 14, 2023
Reiterated: Buy
Price Target: €16.50 → €17.90
Current: €0.88
Upside: n/a
Nov 21, 2023
Reiterated: Buy
Price Target: €30.00 → €33.00
Current: €13.10
Upside: n/a
May 30, 2023
Reiterated: Buy
Price Target: €41.00 → €56.00
Current: €0.77
Upside: n/a
May 5, 2022
Reiterated: Buy
Price Target: €4.20 → €3.50
Current: €0.01
Upside: n/a